Increased Glomerular and Tubular Expression of Transforming Growth Factor-β1, Its Type II Receptor, and Activation of the Smad Signaling Pathway in the db/db Mouse
暂无分享,去创建一个
M. Isono | F. Ziyadeh | S. Chen | Sheldon Chen | M. C. Iglesias-de la Cruz | D. Han | S. Hong | Soon Won Hong | M. C. Iglesias-de la Cruz
[1] S. Hong,et al. Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. , 2000, Journal of the American Society of Nephrology : JASN.
[2] K. Sharma,et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Varga,et al. Interaction of Smad3 with a proximal smad‐binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF‐β , 2000 .
[4] M. Isono,et al. Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. , 2000, American journal of physiology. Renal physiology.
[5] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .
[6] G. King,et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] H. Schnaper,et al. The transforming growth factor-βbgr/SMAD signaling pathway is present and functional in human mesangial cells , 1999 .
[8] D. C. Han,et al. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. , 1999, Journal of the American Society of Nephrology : JASN.
[9] J. Yee,et al. TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. , 1999, Kidney international.
[10] Z. Makita,et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195 , 1999, Diabetologia.
[11] S. Tashiro,et al. ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.
[12] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[13] K. Sharma,et al. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. , 1998, Kidney international.
[14] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[15] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[16] Jia Guo,et al. The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy , 1998, Nephron Experimental Nephrology.
[17] K. Kinzler,et al. Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.
[18] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[19] K. Sharma,et al. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. , 1997, Seminars in nephrology.
[20] H. Abboud,et al. Expression of Transforming Growth Factor-β and Type IV Collagen in Early Streptozotocin-Induced Diabetes , 1997, Diabetes.
[21] C. Chang,et al. Captopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions. , 1996, Journal of the American Society of Nephrology : JASN.
[22] M. Daha,et al. Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. , 1996, Kidney international.
[23] Y. Akai,et al. Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus , 1996 .
[24] Jia Guo,et al. Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice , 1996, Diabetes.
[25] L. Tartaglia,et al. Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.
[26] C. Nast,et al. Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .
[27] F N Ziyadeh,et al. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. , 1995, The Journal of clinical investigation.
[28] K. Sharma,et al. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. , 1994, The American journal of physiology.
[29] K. Thai,et al. Expression of transforming growth factor-β1 during diabetic renal hypertrophy , 1994 .
[30] K. Sharma,et al. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. , 1994, The Journal of clinical investigation.
[31] E Ruoslahti,et al. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] Yasuhiro Watanabe,et al. In situ DNA-protein binding: A novel method for detecting DNA-binding activity of transcription factor in brain , 1992, Neuroscience Letters.
[33] F. Ziyadeh,et al. Hormones, autacoids, and the kidney , 1992 .
[34] R. Weinberg,et al. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.
[35] T. Haverty,et al. Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells. , 1992, Biochimica et biophysica acta.
[36] S. Lee,et al. Early immunopathologic events in experimental diabetic nephropathy: a study in db/db mice. , 1980, Experimental and molecular pathology.
[37] W. Chick,et al. Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. , 1972, The American journal of pathology.
[38] S. J. Chen,et al. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. , 2000, Journal of cellular physiology.
[39] J. Egido,et al. In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. , 1999, Kidney international.
[40] R. Derynck,et al. Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.
[41] H. Abboud,et al. Erratum: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes (Diabetes (1997) 46 (473- 480)) , 1997 .
[42] Y. Akai,et al. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. , 1996, Kidney international.
[43] M. Rocco,et al. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. , 1992, Kidney international.